Global Oncology Biomarker Market Report By Profiling Technology (Omic Technology, Imaging Technology, Immunoassays, And Cytogenetic-Based Tests), By Biomolecule (Genetic Biomarkers, Protein Biomarkers And Glycol-Biomarkers), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer And Others), By Application (Diagnostics, Drug Discovery And Development, Prognostics, Risk Assessment And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210352
January 2020
Report Formats:

As per this study the Global Oncology Biomarker Market was valued USD XX.X BN (by revenue) in 2019 and is anticipated to reach USD 28 BN by 2026 with a CAGR of XX.X%.

A biomarker is referred to as a traceable biomolecule, whose presence found in body fluids such as blood, serum, urine, and tumor fluid that indicates disease or an underlying condition such as cancer. Oncology biomarkers are the biomolecules that are secreted only by tumor cells that leads to diagnosis or prognosis of cancer. Oncology biomarker includes protein, muted genes, DNA, mRNA, and metabolites that aids in the diagnosis of cancer.
 
Market Dynamics
 
Growing count of the population suffering from various types of cancer has created demand of biomarkers leading to early diagnosis and prognosis of cancer. Increase funding by government for cancer diagnosis technique and treatment is fueling the market growth. Owing to a non-invasive method for cancer detection followed by increased cancer awareness is boosting the market growth. In spite of this advantage, high cost associated with diagnosis is restraining the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of oncology biomarker.
 
Market Segmentation
 
The broad oncology biomarker market has been sub-grouped into profiling technology, biomolecule, cancer type, and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Profiling Technology

  • Omics Technology
    • Genomics
    • Proteomics
    • Other Omics Technologies
  • Imaging Technology
  • Immunoassays
  • Cytogenetic-Based Tests
 
By Biomolecule
  • Genetic Biomarkers
  • Protein Biomarkers
  • Glycol-Biomarkers
 
By Cancer Type
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Others
 
By Application
  • Diagnostics
  • Drug Discovery And Development
  • Prognostics
  • Risk Assessment
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for oncology biomarker in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Oncology Biomarker Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the oncology biomarker market include Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, F.Hoffmann-La Roche Ltd., Genomic Health, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Pfizer, Inc. and Qiagen N.V. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

TABLE OF CONTENTS
 
1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Oncology Biomarker Market
       2.2. Global Oncology Biomarker Market Snapshot
 
3 . ONCOLOGY BIOMARKER – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Oncology Biomarker Market
       3.3. Market Restraints of Oncology Biomarker Market
       3.4. Opportunities of Oncology Biomarker Market
       3.5. Trends of Oncology Biomarker Market
       3.6. Porter’s Five Force Analysis of Oncology Biomarker Market
       3.7. Oncology Biomarker Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Profiling Technology
           3.7.2 Market Attractive Analysis by Biomolecule
           3.7.3 Market Attractive Analysis by Cancer Type
           3.7.4 Market Attractive Analysis by Application
           3.7.5 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Oncology Biomarker Value Chain Analysis
       4.2. Oncology Biomarker Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Oncology Biomarker Raw Material Manufactures List
           4.2.3. Price Trend of Oncology Biomarker Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL ONCOLOGY BIOMARKER MARKET ANALYSIS BY PROFILING TECHNOLOGY
       5.1 Overview by Profiling Technology
       5.2 Global Oncology Biomarker Market Analysis by Profiling Technology
       5.3 Market Analysis of Omics Technology by Regions
       5.4 Market Analysis of Imaging Technology by Regions
       5.5 Market Analysis of Immunoassays by Regions
       5.6 Market Analysis of Cytogenetic-Based Tests by Regions
 
6 . GLOBAL ONCOLOGY BIOMARKER MARKET ANALYSIS BY BIOMOLECULE
       6.1 Overview by Biomolecule
       6.2 Global Oncology Biomarker Market Analysis by Biomolecule
       6.3 Market Analysis of Genetic Biomarkers by Regions
       6.4 Market Analysis of Protein Biomarkers by Regions
       6.5 Market Analysis of Glycol-Biomarkers by Regions
 
7 . GLOBAL ONCOLOGY BIOMARKER MARKET ANALYSIS BY CANCER TYPE
       7.1 Overview by Cancer Type
       7.2 Global Oncology Biomarker Market Analysis by Cancer Type
       7.3 Market Analysis of Lung Cancer by Regions
       7.4 Market Analysis of Breast Cancer by Regions
       7.5 Market Analysis of Colorectal Cancer by Regions
       7.6 Market Analysis of Prostate Cancer by Regions
       7.7 Market Analysis of Stomach Cancer by Regions
       7.8 Market Analysis of Others by Regions
 
8 . GLOBAL ONCOLOGY BIOMARKER MARKET ANALYSIS BY APPLICATION
       8.1 Overview by Application
       8.2 Global Oncology Biomarker Market Analysis by Application
       8.3 Market Analysis of Diagnostics by Regions
       8.4 Market Analysis of Drug Discovery And Development by Regions
       8.5 Market Analysis of Prognostics by Regions
       8.6 Market Analysis of Risk Assessment by Regions
       8.7 Market Analysis of Others by Regions
 
9 . GLOBAL ONCOLOGY BIOMARKER MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Oncology Biomarker Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Oncology Biomarker Market Estimate by Market Segment
           9.4.3. Europe Oncology Biomarker Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Oncology Biomarker Market Estimate by Market Segment
           9.5.3. Asia Pacific Oncology Biomarker Market Estimate by Country
           9.5.4. China
           9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Oncology Biomarker Market Estimate by Market Segment
           9.6.3. Latin America Oncology Biomarker Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Oncology Biomarker Market Estimate by Market Segment
           9.7.3. Middle East & Africa Oncology Biomarker Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa
 
10 COMPETITIVE LANDSCAPE OF THE ONCOLOGY BIOMARKER COMPANIES
       10.1. Oncology Biomarker Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 COMPANY PROFILES OF ONCOLOGY BIOMARKER INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Abbott Laboratories
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Bristol-Myers Squibb
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Eli Lilly and Company
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. F.Hoffmann-La Roche Ltd.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Genomic Health, Inc.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. GlaxoSmithKline plc
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Novartis AG, Merck & Co., Inc.
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Pfizer, Inc.
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Qiagen N.V.
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Oncology Biomarker Market Snapshot
  • Drivers of The Global Oncology Biomarker Market Impact Analysis
  • Restraints of The Global Oncology Biomarker Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Global Oncology Biomarker Market Analysis in Omics Technology by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Imaging Technology by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Immunoassays by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Cytogenetic-Based Tests by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis by Biomolecule (USD MN)
  • Global Oncology Biomarker Market Analysis in Genetic Biomarkers by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Protein Biomarkers by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Glycol-Biomarkers by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis by Cancer Type (USD MN)
  • Global Oncology Biomarker Market Analysis in Lung Cancer by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Breast Cancer by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Colorectal Cancer by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Prostate Cancer by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Stomach Cancer by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Others by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis by Application (USD MN)
  • Global Oncology Biomarker Market Analysis in Diagnostics by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Drug Discovery And Development by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Prognostics by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Risk Assessment by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Others by Geography (USD MN)
  • Global Oncology Biomarker Market by Geography (USD MN)
  • North America Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • North America Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • North America Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • North America Oncology Biomarker Market Estimate by Application (USD MN)
  • North America Oncology Biomarker Market Estimate by Country (USD MN)
  • United State Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • United State Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • United State Oncology Biomarker Market Analysis by Cancer Type (USD MN)
  • United State Oncology Biomarker Market Estimate by Application (USD MN)
  • Rest of North America Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Rest of North America Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • Rest of North America Oncology Biomarker Market Estimate by Cancer Type(USD MN)
  • Rest of North America Oncology Biomarker Market Estimate by Application(USD MN)
  • Europe Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Europe Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • Europe Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • Europe Oncology Biomarker Market Estimate by Application (USD MN)
  • Europe Oncology Biomarker Market Estimate by Country (USD MN)
  • United Kingdom Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • United Kingdom Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • United Kingdom Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • United Kingdom Oncology Biomarker Market Estimate by Application (USD MN)
  • France Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • France Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • France Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • France Oncology Biomarker Market Estimate by Application (USD MN)
  • Germany Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Germany Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • Germany Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • Germany Oncology Biomarker Market Estimate by Application (USD MN)
  • Rest of Europe Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Rest of Europe Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • Rest of Europe Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • Rest of Europe Oncology Biomarker Market Estimate by Application (USD MN)
  • Asia Pacific Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Asia Pacific Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • Asia Pacific Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • Asia Pacific Oncology Biomarker Market Estimate by Application (USD MN)
  • Asia Pacific Oncology Biomarker Market Estimate by Country (USD MN)
  • China Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • China Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • China Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • China Oncology Biomarker Market Estimate by Application (USD MN)
  • Japan Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Japan Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • Japan Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • Japan Oncology Biomarker Market Estimate by Application(USD MN)
  • India Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • India Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • India Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • India Oncology Biomarker Market Estimate by Application (USD MN)
  • Rest of Asia Pacific Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Rest of Asia Pacific Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • Rest of Asia Pacific Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • Rest of Asia Pacific Oncology Biomarker Market Estimate by Application (USD MN)
  • Latin America Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Latin America Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • Latin America Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • Latin America Oncology Biomarker Market Estimate by Application (USD MN)
  • Latin America Oncology Biomarker Market Estimate by Country (USD MN)
  • Brazil Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Brazil Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • Brazil Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • Brazil Oncology Biomarker Market Estimate by Application (USD MN)
  • Rest of Latin America Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Rest of Latin America Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • Rest of Latin America Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • Rest of Latin America Oncology Biomarker Market Estimate by Application (USD MN)
  • Middle East & Africa Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Middle East & Africa Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • Middle East & Africa Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • Middle East & Africa Oncology Biomarker Market Estimate by Application (USD MN)
  • Middle East & Africa Oncology Biomarker Market Estimate by Country (USD MN)
  • Middle East Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Middle East Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • Middle East Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • Middle East Oncology Biomarker Market Estimate by Application (USD MN)
  • Africa Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Africa Oncology Biomarker Market Estimate by Biomolecule (USD MN)
  • Africa Oncology Biomarker Market Estimate by Cancer Type (USD MN)
  • Africa Oncology Biomarker Market Estimate by Application (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Oncology Biomarker Report
  • Market Research Process
  • Market Research Methodology
  • Global Oncology Biomarker Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Profiling Technology
  • Market Attractiveness Analysis by Biomolecule
  • Market Attractiveness Analysis by Cancer Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Oncology Biomarker Market Analysis by Profiling Technology (USD MN)
  • Global Oncology Biomarker Market Analysis in Omics Technology by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Imaging Technology by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Immunoassays by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Cytogenetic-Based Tests by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis by Biomolecule (USD MN)
  • Global Oncology Biomarker Market Analysis in Genetic Biomarkers by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Protein Biomarkers by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Glycol-Biomarkers by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis by Cancer Type (USD MN)
  • Global Oncology Biomarker Market Analysis in Lung Cancer by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Breast Cancer by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Colorectal Cancer by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Prostate Cancer by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Stomach Cancer by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Others by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis by Application (USD MN)
  • Global Oncology Biomarker Market Analysis in Diagnostics by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Drug Discovery And Development by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Prognostics by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Risk Assessment by Geography (USD MN)
  • Global Oncology Biomarker Market Analysis in Others by Geography (USD MN)
  • Latin America Oncology Biomarker Market by Revenue
  • Middle East & Africa Oncology Biomarker Market by Revenue
  • Recent Development in Oncology Biomarker Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials